Clinical Trial Update: Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating immunotherapy with gamma delta T cells for hepatocellular carcinoma; the study sponsored by Rennes University Hospital has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gamma Delta T Cells

Snippet

Sponsor: Rennes University Hospital | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: TERMINATED